Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Patients with type 2 diabetes taking sitagliptin or exenatide have double the risk of being hospitalised for acute pancreatitis, compared with those not taking the drugs, say researchers.
The study
A US database was used to gather data on 1,269 cases of patients with type 2 diabetes that had suffered an incidence of acute pancreatitis. Patients were aged 18 to 64 years and were matched with 1,269 controls that had not suffered acute pancreatitis. Patients exposed to sitagliptin or exenatide were split into current users – those exposed within 30 days before the date of pancreatitis onset – and recent users – those exposed from 30 days to two years.
http://www.pulsetoday.co.uk/clinica...tion-from-acute-pancreatitis/20002216.article
(free registration required)
The study
A US database was used to gather data on 1,269 cases of patients with type 2 diabetes that had suffered an incidence of acute pancreatitis. Patients were aged 18 to 64 years and were matched with 1,269 controls that had not suffered acute pancreatitis. Patients exposed to sitagliptin or exenatide were split into current users – those exposed within 30 days before the date of pancreatitis onset – and recent users – those exposed from 30 days to two years.
http://www.pulsetoday.co.uk/clinica...tion-from-acute-pancreatitis/20002216.article
(free registration required)